NewsRx

Search our medical news database

Pathogenesis (HCV)

"Hepatitis C Virus Replication Systems Using Two Cultured Cell Lines."

Published in Hepatitis Weekly, October 20th, 1997

According to an abstract submitted by the authors to the 4th International Meeting on Hepatitis C Virus and Related Viruses, Molecular Virology and Pathogenesis, held March 6-10, 1997, in Kyoto, Japan, "We recently developed hepatitis C virus (HCV) replication systems by using two cultured human cell lines: MT-2, a human T-cell leukemia virus type 1-infected cell line, and PH5CH, a non-neoplastic human hepatocyte line. Furthermore, we obtained cloned MT-2C and PH5CH1 cells, which are more susceptible than the original MT-2 and PH5CH cells, respectively, to HCV infection and can support HCV replication over 30 days post-inoculation (p.i.). We obtained several evidences regarding HCV...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook